Long-term therapy with paricalcitol for secondary hyperparathyroidism in hemodialysis patients

被引：0
|
作者：
机构：
[1] Barton Pai, A.
[2] Lin, S.
[3] Arruda, J.A.L.
[4] Lau, Alan H.
来源：
Lau, A.H. (alanlau@uic.edu) | 1600年 / Wichtig Editore s.r.l.卷 / 26期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [11] CONTROL OF SECONDARY HYPERPARATHYROIDISM DURING LONG-TERM HEMODIALYSIS
    GOLDSMITH, RS
    FURSZYFER, J
    JOHNSON, WJ
    FOURNIER, AE
    ARNAUD, CD
    AMERICAN JOURNAL OF MEDICINE, 1971, 50 (05): : 692 - +
  • [12] Long-term outcomes of cinacalcet and paricalcitol titration protocol for treatment of secondary hyperparathyroidism
    Lazar, Eric
    Hebert, Katrina
    Poma, Tammy
    Stankus, Nicole
    AMERICAN JOURNAL OF NEPHROLOGY, 2007, 27 (03) : 274 - 278
  • [13] Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits
    Xiu Chen
    Feng Zhao
    Wei-Juan Pan
    Jia-Mei Di
    Wei-Nan Xie
    Ling Yuan
    Zhi Liu
    World Journal of Clinical Cases, 2021, (33) : 10172 - 10179
  • [14] Efficacy of Paricalcitol in the Treatment of Secondary Hyperparathyroidism in Maintenance Hemodialysis Patients
    Ou, Santao
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 920 - 920
  • [15] Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits
    Chen, Xiu
    Zhao, Feng
    Pan, Wei-Juan
    Di, Jia-Mei
    Xie, Wei-Nan
    Yuan, Ling
    Liu, Zhi
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (33) : 10172 - 10179
  • [16] Effective treatment of secondary hyperparathyroidism with paricalcitol in chronic hemodialysis patients
    Kampouris, H.
    Orfanaki, G.
    Kapsos, A.
    Rudenko, I.
    Grekas, D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 131 - 131
  • [17] Treatment of secondary hyperparathyroidism with paricalcitol with or without cinacalcet in hemodialysis patients
    Zawierucha, Jacek
    Malyszko, Jolanta
    Malyszko, Jacek S.
    Prystacki, Tomasz
    Marcinkowski, Wojciech
    Dryl-Rydzynska, Teresa
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (12): : 840 - 845
  • [18] HYPERPARATHYROIDISM IN LONG-TERM HEMODIALYSIS (HD) PATIENTS
    REICHEL, H
    KILBURG, M
    RITZ, E
    KIDNEY INTERNATIONAL, 1992, 41 (02) : 491 - 491
  • [19] Effect of paricalcitol on biochemical markers of secondary hyperparathyroidism in hemodialysis patients
    Zdravkovic, J.
    Georgijev, D. Ristic
    Zdravkovic, A.
    Zdravkovic, K.
    Popovic, M.
    Stojanovic, S.
    CLINICA CHIMICA ACTA, 2024, 558
  • [20] LONG-TERM EFFICACY AND SAFETY OF ETELCALCETIDE IN HEMODIALYSIS PATIENTS WITH SEVERE SECONDARY HYPERPARATHYROIDISM
    Massimetti, Carlo
    Micarelli, David
    Feriozzi, Sandro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1717 - 1717
12345